Afgelast
The computed 12-month bankruptcy probability of Afgelast is 5.1% (elevated). The 2024 annual accounts show negative equity (€-13k) and a net result of €-19k. Its solvency ranks better than 5% of 691 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-13k |
| Net result | €-19k |
| Better than sector | 5% |
| Active | 3 yrs |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -73.1% | 39.4% | |
| Net result | €-19k | €13k | |
| Equity | €-13k | €37k | |
| Gross operating margin | €-10k | €39k | |
| Total assets | €17k | €110k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-18k |
| Net profit | €-19k |
| Cash flow | €-18k |
| Staff costs | - |
| Income taxes | €140 |
| Dividends | - |
| Total assets | €17k |
| Equity | €-13k |
| Debt | €30k |
| of which ≤ 1y | €22k |
| of which > 1y | €8k |
| Working capital | €-15k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.32 |
| Quick ratio | 0.32 |
| Working capital ratio | -86.0% |
| Solvency | -73.1% |
| Debt / equity | -2.37 |
| Long-term debt ratio | -0.63 |
| Interest coverage | -57.65 |
| Gross margin | - |
| Net margin | - |
| ROA | -113.2% |
| ROE | 154.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €17k |
| Fixed assets | 21/28 | €10k |
| Formation expenses | 20 | €0 |
| Tangible fixed assets | 22/27 | €10k |
| Current assets | 29/58 | €7k |
| Amounts receivable within one year | 40/41 | €6k |
| Cash & bank | 54/58 | €43 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €17k |
| Equity | 10/15 | €-13k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €0 |
| Accumulated profits (losses) | 14 | €-16k |
| Amounts payable | 17/49 | €30k |
| Amounts payable after one year | 17 | €8k |
| Amounts payable within one year | 42/48 | €22k |
| Trade debts payable within one year | 44 | €800 |
| Income statement | ||
| Gross operating margin | 9900 | €-10k |
| Operating result | 9901 | €-20k |
| Financial income | 75 | €611 |
| Financial charges | 65 | €307 |
| Result before taxes | 9903 | €-19k |
| Income taxes | 67/77 | €140 |
| Net result for the period | 9904 | €-19k |
| Result to be appropriated | 9905 | €-19k |
| NACE primary | 25530 |
| Legal form | Private limited company(610) |
| Incorporation | 14-06-2023 |
| Status | Active |
| Postal code | 9040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44432C1171/00A005 | Flanders | 112 m² | 1 · 79 m² | 12.8 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Afgelast |